Rockwell Medical, Inc. provided financial guidance for the year 2023. For the period, the company expects net sales to be between $82.0 million and $86.0 million, which represents an increase of 17% to 18% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +3.66% | +5.59% | -10.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.05% | 49.92M | |
+29.98% | 682B | |
+31.53% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+17.02% | 240B | |
+10.02% | 209B | |
-8.18% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Financial Guidance for the Year 2023